Publications de la R&D d'Unicancer

2018

GEMO, a national resource to study genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 pathogenic variant carriers

Lesueur F. et al, Front Oncol. 2018 Oct 31;8:490. doi: 10.3389/fonc.2018.00490. eCollection 2018.

2018

The Influence of Number and Timing of Pregnancies on Breast Cancer Risk in Women with BRCA1 and BRCA2 mutations

Terry MB et al, JNCI Cancer Spectr. 2018 Dec;2(4):pky078. doi: 10.1093/jncics/pky078. Epub 2019 Mar 8.

2018

Efficacy of Anthracycline/taxane based neoadjuvant chemotherapy on Triple-Negative Breast Cancer in BRCA1 / BRCA2 mutation carriers.

Bignon L. et al, Breast J 2018 Volume24, Issue3May/June 2018Pages 269-277. Article DOI: 10.1111/tbj.12887

2016

Mutation screening of MIR146A/B and BRCA1/2 3'UTRs in the GENESIS study

Garcia AI et al., Eur J Hum Genet. 2016 Aug;24(9):1324-9.

2015

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results.

Bureau E et al, Health Expect. 2015 Dec;18(6):2425-36. doi: 10.1111/hex.12211. Epub 2014 May 30